vs
Side-by-side financial comparison of Katapult Holdings, Inc. (KPLT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $73.9M, roughly 1.0× Katapult Holdings, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 17.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-12.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.6%).
Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
KPLT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $73.9M | $75.5M |
| Net Profit | $19.8M | — |
| Gross Margin | 15.6% | 69.3% |
| Operating Margin | -1.4% | 22.7% |
| Net Margin | 26.8% | — |
| Revenue YoY | 17.3% | 27.7% |
| Net Profit YoY | 307.3% | — |
| EPS (diluted) | $3.69 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $73.9M | $75.5M | ||
| Q3 25 | $74.0M | $54.5M | ||
| Q2 25 | $71.9M | $52.4M | ||
| Q1 25 | $71.9M | $46.0M | ||
| Q4 24 | $63.0M | $59.1M | ||
| Q3 24 | $60.3M | $80.5M | ||
| Q2 24 | $58.9M | $47.1M | ||
| Q1 24 | $65.1M | $43.8M |
| Q4 25 | $19.8M | — | ||
| Q3 25 | $-4.9M | $8.8M | ||
| Q2 25 | $-7.8M | $5.9M | ||
| Q1 25 | $-5.7M | $3.0M | ||
| Q4 24 | $-9.6M | — | ||
| Q3 24 | $-8.9M | $20.3M | ||
| Q2 24 | $-6.9M | $-4.5M | ||
| Q1 24 | $-570.0K | $-4.8M |
| Q4 25 | 15.6% | 69.3% | ||
| Q3 25 | 19.7% | 77.7% | ||
| Q2 25 | 15.5% | 76.5% | ||
| Q1 25 | 19.9% | 77.1% | ||
| Q4 24 | 11.8% | 76.4% | ||
| Q3 24 | 19.8% | 63.9% | ||
| Q2 24 | 16.9% | 77.4% | ||
| Q1 24 | 25.3% | 75.5% |
| Q4 25 | -1.4% | 22.7% | ||
| Q3 25 | 3.3% | 17.6% | ||
| Q2 25 | -2.0% | 12.7% | ||
| Q1 25 | -0.7% | 8.7% | ||
| Q4 24 | -7.7% | 22.6% | ||
| Q3 24 | -7.4% | 27.4% | ||
| Q2 24 | -4.5% | -4.6% | ||
| Q1 24 | 5.8% | -5.3% |
| Q4 25 | 26.8% | — | ||
| Q3 25 | -6.7% | 16.2% | ||
| Q2 25 | -10.9% | 11.2% | ||
| Q1 25 | -7.9% | 6.5% | ||
| Q4 24 | -15.2% | — | ||
| Q3 24 | -14.7% | 25.2% | ||
| Q2 24 | -11.7% | -9.6% | ||
| Q1 24 | -0.9% | -11.0% |
| Q4 25 | $3.69 | $0.26 | ||
| Q3 25 | $-0.94 | $0.17 | ||
| Q2 25 | $-1.63 | $0.12 | ||
| Q1 25 | $-1.23 | $0.06 | ||
| Q4 24 | $-2.17 | $0.40 | ||
| Q3 24 | $-2.05 | $0.41 | ||
| Q2 24 | $-1.61 | $-0.09 | ||
| Q1 24 | $-0.13 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.4M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-38.1M | $130.3M |
| Total Assets | $107.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.4M | $97.5M | ||
| Q3 25 | $3.4M | $94.4M | ||
| Q2 25 | $3.7M | $96.0M | ||
| Q1 25 | $6.0M | $93.2M | ||
| Q4 24 | $3.5M | $101.0M | ||
| Q3 24 | $25.9M | $96.7M | ||
| Q2 24 | $33.7M | $96.8M | ||
| Q1 24 | $31.2M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $-38.1M | $130.3M | ||
| Q3 25 | $-58.4M | $115.3M | ||
| Q2 25 | $-54.1M | $104.7M | ||
| Q1 25 | $-51.7M | $97.1M | ||
| Q4 24 | $-46.8M | $92.1M | ||
| Q3 24 | $-40.3M | $71.1M | ||
| Q2 24 | $-32.9M | $48.5M | ||
| Q1 24 | $-27.5M | $51.0M |
| Q4 25 | $107.9M | $216.3M | ||
| Q3 25 | $85.9M | $202.9M | ||
| Q2 25 | $90.6M | $194.9M | ||
| Q1 25 | $88.5M | $196.2M | ||
| Q4 24 | $93.2M | $213.3M | ||
| Q3 24 | $92.0M | $220.7M | ||
| Q2 24 | $106.6M | $205.0M | ||
| Q1 24 | $106.6M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.9M | $14.4M |
| Free Cash FlowOCF − Capex | $-12.0M | $14.4M |
| FCF MarginFCF / Revenue | -16.2% | 19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.60× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.9M | $14.4M | ||
| Q3 25 | $4.0M | $9.7M | ||
| Q2 25 | $-6.6M | $14.1M | ||
| Q1 25 | $3.4M | $3.6M | ||
| Q4 24 | $-32.6M | $15.6M | ||
| Q3 24 | $-5.4M | $11.0M | ||
| Q2 24 | $-628.0K | $1.0M | ||
| Q1 24 | $2.0M | $11.2M |
| Q4 25 | $-12.0M | $14.4M | ||
| Q3 25 | $4.0M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $3.4M | $3.6M | ||
| Q4 24 | $-32.6M | $15.6M | ||
| Q3 24 | $-5.4M | $11.0M | ||
| Q2 24 | $-653.0K | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | -16.2% | 19.1% | ||
| Q3 25 | 5.4% | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | 4.7% | 7.7% | ||
| Q4 24 | -51.8% | 26.4% | ||
| Q3 24 | -9.0% | 13.7% | ||
| Q2 24 | -1.1% | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
| Q4 25 | -0.60× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
